These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11523840)

  • 21. Cognitive styles in hyperactive children and the effect of methylphenidate.
    Campbell SB; Douglas VI; Morgenstern G
    J Child Psychol Psychiatry; 1971 Jun; 12(1):55-67. PubMed ID: 23289169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of methylphenidate on complex cognitive processing in attention-deficit hyperactivity disorder.
    Berman T; Douglas VI; Barr RG
    J Abnorm Psychol; 1999 Feb; 108(1):90-105. PubMed ID: 10066996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of stimulant drugs on curiosity behaviors of hyperactive boys.
    Fiedler NL; Ullman DG
    J Abnorm Child Psychol; 1983 Jun; 11(2):193-206. PubMed ID: 6619433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder.
    O'Driscoll GA; Dépatie L; Holahan AL; Savion-Lemieux T; Barr RG; Jolicoeur C; Douglas VI
    Biol Psychiatry; 2005 Jun; 57(11):1452-60. PubMed ID: 15950020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-hyperactivity medication: methylphenidate and amphetamine.
    Seeman P; Madras BK
    Mol Psychiatry; 1998 Sep; 3(5):386-96. PubMed ID: 9774771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylphenidate and growth in hyperactive children. A controlled withdrawal study.
    Klein RG; Landa B; Mattes JA; Klein DF
    Arch Gen Psychiatry; 1988 Dec; 45(12):1127-30. PubMed ID: 3058088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-Dose Methylphenidate-Induced Changes in Brain Functional Connectivity Are Correlated With 3-Month Attention-Deficit/Hyperactivity Disorder Symptom Response.
    Silberstein RB; Levy F; Pipingas A; Farrow M
    Biol Psychiatry; 2017 Nov; 82(9):679-686. PubMed ID: 28465019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peer perceptions of hyperactivity and medication effects.
    Whalen CK; Henker B; Castro J; Granger D
    Child Dev; 1987 Jun; 58(3):816-28. PubMed ID: 3608652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations between motor persistence and plasma levels in methylphenidate-treated boys with ADHD.
    Greenhill LL; Perel JM; Rudolph G; Feldman B; Curran S; Puig-Antich J; Gardner R
    Int J Neuropsychopharmacol; 2001 Jun; 4(2):207-15. PubMed ID: 11466170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The speech of hyperactive children and their mothers: comparison with normal children and stimulant drug effects.
    Barkley RA; Cunningham CE; Karlsson J
    J Learn Disabil; 1983 Feb; 16(2):105-10. PubMed ID: 6842069
    [No Abstract]   [Full Text] [Related]  

  • 31. [Medical treatments of hyperactive child].
    Le Heuzey MF
    Arch Pediatr; 2004 Jan; 11(1):64-9. PubMed ID: 14700769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The course of behaviour changes in children with attention deficit and hyperactivity after drug treatment].
    Roselló B; Pitarch I; Abad L
    Rev Neurol; 2002 Feb; 34 Suppl 1():S82-90. PubMed ID: 12447796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delta plots in the study of individual differences: new tools reveal response inhibition deficits in AD/Hd that are eliminated by methylphenidate treatment.
    Ridderinkhof KR; Scheres A; Oosterlaan J; Sergeant JA
    J Abnorm Psychol; 2005 May; 114(2):197-215. PubMed ID: 15869351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylphenidate effects on global and complex measures of EEG.
    Lubar JF; White JN; Swartwood MO; Swartwood JN
    Pediatr Neurol; 1999 Sep; 21(3):633-7. PubMed ID: 10513690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent Handwriting Difficulties in Children With ADHD After Treatment With Stimulant Medication.
    Brossard-Racine M; Shevell M; Snider L; Bélanger SA; Julien M; Majnemer A
    J Atten Disord; 2015 Jul; 19(7):620-9. PubMed ID: 23160486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulants improve theory of mind in children with attention deficit/hyperactivity disorder.
    Maoz H; Tsviban L; Gvirts HZ; Shamay-Tsoory SG; Levkovitz Y; Watemberg N; Bloch Y
    J Psychopharmacol; 2014 Mar; 28(3):212-9. PubMed ID: 23761389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting methylphenidate response in attention deficit hyperactivity disorder: a preliminary study.
    Johnston BA; Coghill D; Matthews K; Steele JD
    J Psychopharmacol; 2015 Jan; 29(1):24-30. PubMed ID: 25237119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of methylphenidate and expectancy of ADHD children's performance, self-evaluations, persistence, and attributions on a cognitive task.
    Pelham WE; Hoza B; Kipp HL; Gnagy EM; Trane ST
    Exp Clin Psychopharmacol; 1997 Feb; 5(1):3-13. PubMed ID: 9234034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.